SCHEMBL636743

SCHEMBL636743

C[C@@H](c1ccccc1)N1CCCCC1c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.41
MAOA P21397 1/20 0.41
GAA P10253 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP2D6 P10635 1/20 0.40
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.36
MC4R P32245 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RIPK1 Q13546 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24775484 0.81 ALDH1A1 (0.43) MAOBMAOAGAAKDM4EALDH1A1
SCHEMBL18729770 0.81 CHRNB2 (0.49) GAAKDM4ECYP2D6OPRM1OPRD1
SCHEMBL17130333 0.81 CHRNB2 (0.49) GAAKDM4ECYP2D6OPRM1OPRD1
SCHEMBL18751620 0.81 CHRNB2 (0.49) GAAKDM4ECYP2D6OPRM1OPRD1
SCHEMBL9963125 0.81 ALDH1A1 (0.43) MAOBMAOAGAAKDM4EALDH1A1
SCHEMBL18751622 0.76 CYP2D6 (0.41) MAOBMAOAKDM4ECYP2D6OPRM1
SCHEMBL9965914 0.76 ALDH1A1 (0.45) MAOBMAOAGAAKDM4EALDH1A1
SCHEMBL18768490 0.76 KDM4E (0.39) KDM4ECYP2D6OPRM1OPRD1OPRK1
SCHEMBL17114338 0.75 CYP2D6 (0.40) KDM4ECYP2D6OPRM1OPRD1OPRK1
SCHEMBL17114337 0.75 CYP2D6 (0.40) KDM4ECYP2D6OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419433-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-02-22 EP disclosed
WO-2010120621-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-21 WO disclosed